Systemic lupus erythematosus and glycation proces

Systemic lupus erythematosus and glycation proces

Systemic lupus erythematosus (SLE) is a disease of unclear causes, which leads to major immunological disorders. It is characterized by an abnormal immune system activity resulting in the production of autoantibodies. In patients, antibodies targeting normal nuclear components, double-stranded DNA (...

Full description

Bibliographic Details
Main Authors:	Agnieszka Nowak, Brygida Przywara-Chowaniec, Krystyna Tyrpień-Golder, Ewa Nowalany-Kozielska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-04-01
Series:	Central European Journal of Immunology
Subjects:	systemic lupus erythematosus (sle) srage advanced glycation advanced glycation end products smoking ages
Online Access:	https://www.termedia.pl/Systemic-lupus-erythematosus-and-glycation-proces,10,33567,1,1.html

Similar Items

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
by: Deepika Garg, et al.
Published: (2015-12-01)

The plasma level of soluble receptor for advanced glycation end products in systemic lupus erythematosus patients and its relation to disease activity
by: Anna Nashaat Abou-Raya, et al.
Published: (2016-06-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)

Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women
by: Nabigh A NAJI, et al.
Published: (2021-06-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus
by: Chang-Youh Tsai, et al.
Published: (2019-08-01)

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis
by: Suzan Wetzels, et al.
Published: (2017-02-01)

The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle
by: Tatsuro Egawa, et al.
Published: (2019-09-01)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
by: Elena Dozio, et al.
Published: (2020-12-01)

Laporan Kasus Cutaneus Discoid Lupus Erythematosus
by: Sarah Yunara, et al.
Published: (2017-01-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
by: Franziska Diekmann, et al.
Published: (2021-08-01)

A Study on Urinary Glycated Albumin to urinary albumin excretion in gestational diabetes mellitus
by: Chandramallika Paul, et al.
Published: (2021-02-01)

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay
by: Alpana Pande, et al.
Published: (2021-01-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

N-acetylcysteine Counteracts Adipose Tissue Macrophage Infiltration and Insulin Resistance Elicited by Advanced Glycated Albumin in Healthy Rats
by: Karolline S. da Silva, et al.
Published: (2017-09-01)

Cinnamic Acid and Its Derivatives Inhibit Fructose-Mediated Protein Glycation
by: Sirintorn Yibchok-anun, et al.
Published: (2012-02-01)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
by: Anastasia Papagrigoraki, et al.
Published: (2017-11-01)

Acetoacetate enhancement of glucose mediated DNA glycation
by: M. Bagherzadeh-Yazdi, et al.
Published: (2021-03-01)

A novel crosslinked type of advanced glycation end-product derived from lactaldehyde
by: Tomoaki Shigeta, et al.
Published: (2020-11-01)

Formation and inhibition of advanced glycation endproducts in meat and model systems
by: Chen, Gengjun
Published: (2016)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways
by: Amit Porat, et al.
Published: (2018-12-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

The effect of advanced glycation endproduct accumulation on bone
by: Van Vliet, Miranda
Published: (2017)

Evaluation of in vitro sucrase Inhibitory and non-enzymatic glycation properties of Ocimum tenuiflorum L. leaves
by: Antora, R.A., et al.
Published: (2018-05-01)

Dietary Advanced Glycation End Products and Aging
by: Karen Chapman-Novakofski, et al.
Published: (2010-12-01)

Direct immunofluorescence in Lupus Erythematosus (LE)
by: Roseli Svartman Isfer, et al.

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01)

Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
by: Elom K. Aglago, et al.
Published: (2021-09-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Cannot write session to /tmp/vufind_sessions/sess_2r458lsvtmkc1ldcnu5mlnjqt6